Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Capitol Federal Financial | CFFN | Oct 15, 2024 | 6.02 | +2.03 |
Capri Holdings | CPRI | Oct 15, 2024 | 43.04 | -0.02 |
Capricor Therapeutics | CAPR | Oct 15, 2024 | 21.60 | +10.32 |
Captivision | CAPT | Oct 15, 2024 | 1.79 | -5.79 |
Cara Therapeutics | CARA | Oct 15, 2024 | 0.26 | -0.43 |
Caravelle International Group | CACO | Oct 15, 2024 | 0.44 | 0.00 |
Carbon Revolution | CREV | Oct 15, 2024 | 3.64 | +1.17 |
Cardiff Oncology | CRDF | Oct 15, 2024 | 2.67 | +1.52 |
Cardinal Health | CAH | Oct 15, 2024 | 111.98 | +0.05 |
Cardio Diagnostics | CDIO | Oct 15, 2024 | 0.21 | +1.61 |
Cardiol Therapeutics | CRDL | Oct 15, 2024 | 1.91 | +3.80 |
Cardlytics | CDLX | Oct 15, 2024 | 3.77 | +0.13 |
CareCloud | CCLD | Oct 15, 2024 | 2.50 | +2.04 |
CareCloud A Pref | CCLDP | Oct 15, 2024 | 11.20 | -0.97 |
CareCloud B Pref | CCLDO | Oct 15, 2024 | 11.77 | -2.26 |
CareDx | CDNA | Oct 15, 2024 | 26.35 | -15.84 |
CareMax A | CMAX | Oct 15, 2024 | 1.96 | +13.95 |
CareTrust REIT | CTRE | Oct 15, 2024 | 30.61 | +1.36 |
CARGO Therapeutics | CRGX | Oct 15, 2024 | 21.85 | +7.79 |
CarGurus A | CARG | Oct 15, 2024 | 31.45 | +1.06 |
Caribou Biosciences | CRBU | Oct 15, 2024 | 1.95 | +2.63 |
Carisma Therapeutics | CARM | Oct 15, 2024 | 0.95 | +0.48 |
Carlisle Companies | CSL | Oct 15, 2024 | 471.54 | -1.95 |
Carlyle Credit Income Fund | CCIA | Oct 15, 2024 | 26.05 | +0.70 |
Carlyle Credit Income Fund | CCIF | Oct 15, 2024 | 8.39 | -0.24 |
Carlyle Secured Lending | CGBD | Oct 15, 2024 | 17.40 | +0.87 |
CarMax | KMX | Oct 15, 2024 | 73.67 | +0.86 |
Carmell | CTCX | Oct 15, 2024 | 0.35 | -0.55 |
Carnival | CCL | Oct 15, 2024 | 21.55 | +6.63 |
Carnival ADR | CUK | Oct 15, 2024 | 19.69 | +6.84 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.